Table 3.
Mean Survey Responses
| Women Vignettes | |||||
|---|---|---|---|---|---|
| African-American | White |
P value |
|||
| Mean | (SE) | Mean | (SE) | ||
| TREATMENT RECOMMENDATIONS | |||||
| Heart Transplant | 7.53 | (0.59) | 6.53 | (0.61) | 0.56 |
| Bridge to Transplant VAD | 8.11 | (0.58) | 7.78 | (0.57) | 0.79 |
| Destination VAD | 7.00 | (0.77) | 7.48 | (0.63) | >0.99 |
| No Therapies | 1.40 | (0.18) | 1.43 | (0.25) | >0.99 |
| FACTORS IMPACTING DECISION | |||||
| HPI | 9.45 | (0.23) | 9.33 | (0.21) | 0.79 |
| Age | 9.60 | (0.22) | 9.50 | (0.27) | 0.79 |
| Race or Ethnicity | 9.35 | (0.48) | 7.29 | (0.88) | 0.23 |
| Gender | 9.35 | (0.48) | 7.14 | (0.84) | 0.21 |
| Height/Weight/BMI | 8.40 | (0.47) | 8.08 | (0.42) | 0.79 |
| Insurance | 8.55 | (0.56) | 7.66 | (0.75) | 0.79 |
| Blood Type & PRA | 9.05 | (0.51) | 8.85 | (0.48) | 0.79 |
| Cardiac History | 9.75 | (0.14) | 9.85 | (0.11) | 0.85 |
| NYHA & Vitals | 9.65 | (0.25) | 9.75 | (0.14) | >0.99 |
| Medications | 9.70 | (0.13) | 9.25 | (0.42) | 0.91 |
| Other Medical/Surgical History | 8.70 | (0.38) | 8.73 | (0.28) | 0.91 |
| Social History | 8.20 | (0.39) | 7.65 | (0.42) | 0.79 |
| Adherence | 8.25 | (0.36) | 7.38 | (0.38) | 0.42 |
| Cardiac Diagnostic | 9.70 | (0.13) | 9.13 | (0.32) | 0.64 |
| Pulmonary Studies | 9.75 | (0.14) | 8.60 | (0.35) | 0.08 |
| Laboratory test | 8.95 | (0.32) | 8.53 | (0.36) | 0.79 |
| Infectious Disease | 9.90 | (0.07) | 9.35 | (0.26) | 0.42 |
| Cancer Screening | 9.80 | (0.14) | 9.05 | (0.48) | 0.45 |
| Additional Studies | 8.00 | (0.64) | 7.83 | (0.57) | 0.85 |
Likert scores are 1 to 10, with 10 representing greatest support and 1 least support for offering advanced heart failure therapies. P values have been adjusted for false discovery rate. BMI indicates body mass index; FDR, false determination rate; HPI, history of present illness; NYHA, New York Heart Association; PRA, panel-reactive antibody; SE, standard error; VAD, ventricular assist device.